Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery

The mission of the Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) is to accelerate the development of a preventative HIV vaccine through state-of-the-art technologies and advanced knowledge in immunological and clinical research, genomics, bioinformatics and proteomics.

Funded by a seven-year grant from the National Institutes of Health, the center will conduct multidisciplinary research into immune responses that prevent infection or control the virus in infected individuals. The team will also generate vaccine components to induce such immune responses and provide broad protection against HIV infection.

Led by Scripps Research Professor Dennis Burton, the project also includes scientists at Beth Israel Medical Center, Emory University, Fred Hutchinson Cancer Research Center, La Jolla Institute for Allergy & Immunology, Oxford University, The Ragon Institute, The Rockefeller University, Howard Hughes Medical Institute, Sanford-Burnham Medical Research Institute and others at Scripps Research.